These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7181063)

  • 21. [Experimental study of dantrolene sodium in anesthetic malignant hyperthermia in the pietrain-strain pig].
    Adnet P; Krivosic-Horber R; Guevart E; Theunynck D; Vincent A
    Cah Anesthesiol; 1986 Oct; 34(6):463-7. PubMed ID: 3801956
    [No Abstract]   [Full Text] [Related]  

  • 22. Malignant hyperthermia: clinical course and metabolic changes in two patients.
    Rutberg H; Håkanson E
    Acta Anaesthesiol Scand; 1986 Apr; 30(3):211-4. PubMed ID: 3739577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of CO2, calcium, digoxin, and potassium on cardiac and skeletal muscle metabolism in malignant hyperthermia susceptible swine.
    Gronert GA; Ahern CP; Milde JH; White RD
    Anesthesiology; 1986 Jan; 64(1):24-8. PubMed ID: 3079972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug treatment of malignant hyperpyrexia.
    Austin KL; Denborough MA
    Anaesth Intensive Care; 1977 Aug; 5(3):207-13. PubMed ID: 900461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal membrane properties of the sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia: modes of action of halothane, caffeine, dantrolene, and two other drugs.
    Ohnishi ST; Waring AJ; Fang SR; Horiuchi K; Flick JL; Sadanaga KK; Ohnishi T
    Arch Biochem Biophys; 1986 Jun; 247(2):294-301. PubMed ID: 2424370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of prophylactic or therapeutic efficacy of 5-HT2A receptor antagonists in halothane-induced porcine malignant hyperthermia.
    Löscher W; Gerdes C; Richter A
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):365-74. PubMed ID: 7845474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of dantrolene on myoplasmic free [Ca2+] measured in vivo in patients susceptible to malignant hyperthermia.
    Lopez JR; Gerardi A; Lopez MJ; Allen PD
    Anesthesiology; 1992 May; 76(5):711-9. PubMed ID: 1575338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dantrolene in human malignant hyperthermia.
    Kolb ME; Horne ML; Martz R
    Anesthesiology; 1982 Apr; 56(4):254-62. PubMed ID: 7039419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do we foresee new emerging drugs to treat malignant hyperthermia?
    Just KS; Gerbershagen MU; Grensemann J; Wappler F
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):161-4. PubMed ID: 25736705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Verapamil is not a therapeutic adjunct to dantrolene in porcine malignant hyperthermia.
    Gallant EM; Foldes FF; Rempel WE; Gronert GA
    Anesth Analg; 1985 Jun; 64(6):601-6. PubMed ID: 4003778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.
    Harrison GG
    Br J Anaesth; 1977 Apr; 49(4):315-7. PubMed ID: 889645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
    Ward A; Chaffman MO; Sorkin EM
    Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porcine malignant hyperthermia. VII: Hepatic metabolism.
    Hall GM; Lucke JN; Lovell R; Lister D
    Br J Anaesth; 1980 Jan; 52(1):11-7. PubMed ID: 6990947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological distinction between dantrolene and ryanodine binding sites: evidence from normal and malignant hyperthermia-susceptible porcine skeletal muscle.
    Palnitkar SS; Mickelson JR; Louis CF; Parness J
    Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):847-52. PubMed ID: 9307036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anaesthesia of pigs sensitive to malignant hyperthermia.
    Lucke JN; Hall GM; Lister D
    Vet Rec; 1977 Jan; 100(3):45-8. PubMed ID: 319590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A survey for prevention and treatment of malignant hyperthermia in Taiwan.
    Yip WH; Mingi CL; Ooi SJ; Chen SC; Chiang YY
    Acta Anaesthesiol Taiwan; 2004 Sep; 42(3):147-51. PubMed ID: 15551892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dantrolene--a review of its pharmacology, therapeutic use and new developments.
    Krause T; Gerbershagen MU; Fiege M; Weisshorn R; Wappler F
    Anaesthesia; 2004 Apr; 59(4):364-73. PubMed ID: 15023108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacological Treatment of Malignant Hyperthermia: Update 2019].
    Schuster F; Johannsen S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2019 Sep; 54(9):549-558. PubMed ID: 31525788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant hyperthermia with excellent response to small dose of dantrolene.
    Chang KY; Ting CK; Chan KH; Tsai SK
    Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):241-5. PubMed ID: 15679136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous lecithin-coated microcrystals of dantrolene are effective in the treatment of malignant hyperthermia: an investigation in rats, dogs, and swine.
    Karan SM; Lojeski EW; Haynes DH; Bina S; Wesche DL; Boedeker BH; Muldoon SM
    Anesth Analg; 1996 Apr; 82(4):796-802. PubMed ID: 8615500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.